BACK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BACK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
IMAC Holdings's average Accounts Receivable for the three months ended in Dec. 2024 was $0.04 Mil. IMAC Holdings's Revenue for the three months ended in Dec. 2024 was $0.00 Mil.
The historical rank and industry rank for IMAC Holdings's Days Sales Outstanding or its related term are showing as below:
During the past 9 years, IMAC Holdings's highest Days Sales Outstanding was 145.32. The lowest was 12.06. And the median was 36.98.
IMAC Holdings's Days Sales Outstanding stayed the same from Dec. 2023 (0.00) to Dec. 2024 (0.00).
The historical data trend for IMAC Holdings's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IMAC Holdings Annual Data | |||||||||||||||||||
Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | ||||||||||
Days Sales Outstanding | Get a 7-Day Free Trial |
![]() |
39.41 | 34.54 | - | - | 141.94 |
IMAC Holdings Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Days Sales Outstanding | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | 91.25 | 47.25 | - |
For the Medical Care Facilities subindustry, IMAC Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, IMAC Holdings's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where IMAC Holdings's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Accounts Receivable can be measured by Days Sales Outstanding.
IMAC Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as
Days Sales Outstanding (A: Dec. 2024 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Dec. 2023 ) | + | Accounts Receivable (A: Dec. 2024 )) | / | count ) | / | Revenue (A: Dec. 2024 ) | * | Days in Period |
= | ( (0 | + | 0.028) | / | 1 ) | / | 0.072 | * | 365 |
= | 0.028 | / | 0.072 | * | 365 | ||||
= | 141.94 |
IMAC Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:
Days Sales Outstanding (Q: Dec. 2024 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Sep. 2024 ) | + | Accounts Receivable (A: Dec. 2024 )) | / | count ) | / | Revenue (A: Dec. 2024 ) | * | Days in Period |
= | ( (0.042 | + | 0.028) | / | 2 ) | / | 0 | * | 365 / 4 |
= | 0.035 | / | 0 | * | 365 / 4 | ||||
= | N/A |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IMAC Holdings (OTCPK:BACK) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Thank you for viewing the detailed overview of IMAC Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Benjamin S Lerner | officer: Chief Operating Officer | C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027 |
Matthew C Wallis | director, 10 percent owner, officer: Chief Operating Officer | C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027 |
Michael D Pruitt | director | 11220 ELM LANE, SUITE 203, CHARLOTTE NC 28277 |
Cary Sucoff | director | 1612 EAST CAPE CORAL PKWY, C/O LEGACY EDUCATION ALLIANCE, INC., CAPE CORAL FL 33904 |
Maurice E. Evans | director | C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027 |
Jeffrey S Ervin | director, officer: Chief Executive Officer | C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027 |
Hayden Gerard M Jr | director | C/O PRIVATE BUSINESS INC, P O BOX 1603, BRENTWOOD TN 37024 |
David Ellwanger | director | C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027 |
Sheri Gardzina | officer: Interim CFO | C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027 |
George P Hampton | director | C/O HORIZON PHARMA PLC, 520 LAKE COOK ROAD, STE 520, DEERFIELD IL 60015 |
Dean Weiland | director | C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027 |
Dwight Anthony Bond | officer: Chief Financial Officer | C/O IMAC HOLDINGS, INC., BRENTWOOD TN 37027 |
From GuruFocus
By Marketwired • 02-24-2025
By Marketwired • 08-23-2024
By Marketwired • 09-07-2023
By GlobeNewswire • 08-23-2024
By Ds*** Ds*** • 09-01-2022
By Marketwired • 11-14-2024
By Value_Insider Value_Insider • 11-03-2022
By Marketwired • 05-24-2024
By Marketwired • 06-25-2024
By sperokesalga sperokesalga • 03-01-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.